Health & Peptide Science
Peptide reference
- compounds
- 41
- Research areas
- 8
Research areas
- Anabolic & Growth Factors3
- Cognitive & Neurological7
- Endocrine & Reproductive4
- Growth Hormone Axis6
- Immune & Anti-inflammatory3
- Longevity & Cellular Health8
- Metabolic & Body Composition8
- Recovery & Tissue Repair2
8 / 41 compounds
Research areas
- 1815.1 Da
AOD-9604
Metabolic & Body Composition
15 residuesC-terminal fragment of human growth hormone (hGH 176-191). Studied for β3-adrenergic lipolysis in adipocytes without GH receptor binding.
Half-life: ~30 minOpen entry - 3416.0 Da
Cagrilintide
Metabolic & Body Composition
Long-acting amylin analogue in clinical development. Studied as an amylin receptor agonist that slows gastric emptying and acts on satiety pathways.
Half-life: ~7–8 daysOpen entry - 3298.7 Da
GLP-1 (7-37)
Metabolic & Body Composition
31 residuesEndogenous incretin with a very short native half-life. The molecular reference point for semaglutide and the other GLP-1R agonists.
Half-life: ~2 minutes (native)Open entry - 1817.1 Da
HGH Fragment 176-191
Metabolic & Body Composition
16 residuesStabilised C-terminal fragment of human GH (residues 176-191). Studied for β-adrenergic lipolysis without IGF-1 induction.
Half-life: ~30 minutesOpen entry - 4769.5 Da
Retatrutide
Metabolic & Body Composition
39 residuesTriple GIP, GLP-1 and glucagon receptor agonist in clinical-stage research. Studied for caloric intake pathways and hepatic glucose output.
Half-life: ~6 daysOpen entry - 4113.6 Da
Semaglutide
Metabolic & Body Composition
31 residuesLong-acting GLP-1 analogue studied at GLP-1R for glucose-dependent insulin secretion, gastric emptying and hypothalamic appetite signalling.
Half-life: ~7 daysOpen entry - 5136.0 Da
Tesamorelin
Metabolic & Body Composition
44 residuesGHRH analogue stabilised with trans-3-hexenoic acid. Studied for GHRH receptor binding, IGF-1 output and visceral adipose models.
Half-life: ~30 minOpen entry - 4813.5 Da
Tirzepatide
Metabolic & Body Composition
39 residuesDual GIP and GLP-1 receptor agonist studied for insulin secretion, glucagon suppression and energy expenditure in metabolic models.
Half-life: ~5 daysOpen entry